Wild Biotech
Microbiome-derived Drug Discovery and Development Platform
Company Overview
Snapshot
Founded in April 2019 by Neta Raab and Ido Bachelet, Wild Biotech operates with 1–10 employees. The company has secured funding across one round from Marius Nacht and Tech.bio. In August 2026, Wild Biotech ceased operations.
Business overview
Wild Biotech is an Israeli startup developing an AI-powered drug discovery platform focused on creating new medicines for various illnesses. The company utilizes de novo metagenome assembly and artificial intelligence to build an annotated metagenomic database of wild animal microbiota, analyzing gut microbes based on associations with factors like diet, activity, and lifespans. Wild Biotech's end-to-end process spans field exploration to drug development and clinical trials, initially targeting inflammatory, immune, and gastrointestinal diseases with several lead compounds currently in the preclinical stage. The company operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development.
Strategic signal
In March 2021, Wild Biotech was featured in multiple biotech publications for its innovative approach to drug discovery, specifically its strategy of searching gut microbes from wild animals to pursue new treatments for human diseases. This coverage highlighted the company's unique methodology in leveraging biodiversity for pharmaceutical advancements, signaling a novel direction in microbiome research and drug development.
Company Intelligence Q&A
- What is Wild Biotech's primary focus?
- Wild Biotech is focused on developing an AI-powered drug discovery platform that leverages microbiome-derived insights to create new medicines for a range of illnesses, including inflammatory, immune, and gastrointestinal diseases.
- When was Wild Biotech founded and by whom?
- Wild Biotech was founded in April 2019 by Neta Raab and Ido Bachelet.
- What is the status of Wild Biotech?
- Wild Biotech ceased operations in August 2026.
- What technology does Wild Biotech use for drug discovery?
- Wild Biotech uses an AI-powered platform that employs de novo metagenome assembly to create an annotated metagenomic database of wild animal microbiota, analyzing gut microbes to identify potential drug candidates.